EVIDENCE OF TOLERANCE DEVELOPMENT TO THE HYPERPHAGIC BUT NOT ANXIOLYTIC-LIKE ACTIONS OF SB-200646A, A 5-HT2C/5-HT2B RECEPTOR ANTAGONIST, AFTER CHRONIC TREATMENT

被引:0
|
作者
KENNETT, GA [1 ]
GREWAL, S [1 ]
BLACKBURN, TP [1 ]
机构
[1] SMITHKLINE BEECHAM PHARMACEUT,HARLOW CM19 5AW,ESSEX,ENGLAND
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:P370 / P370
页数:1
相关论文
共 50 条
  • [11] IS MIGRAINE PROPHYLACTIC ACTIVITY CAUSED BY 5-HT2B OR 5-HT2C RECEPTOR BLOCKADE
    KALKMAN, HO
    LIFE SCIENCES, 1994, 54 (10) : 641 - 644
  • [12] ABSENCE OF AN ANXIOLYTIC EFFECT OF THE 5-HT2C/2B ANTAGONIST SB200646A IN THE CONDITIONED EMOTIONAL RESPONSE MODEL OF ANXIETY IN THE RAT
    OXLEY, K
    STANHOPE, KJ
    SHEPHERD, JK
    CRONIN, S
    DOURISH, CT
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 : P215 - P215
  • [13] Expression of 5-HT2A, 5-HT2B and 5-HT2C receptors in the mouse embryo
    Lauder, JM
    Wilkie, MB
    Wu, C
    Singh, S
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2000, 18 (07) : 653 - 662
  • [14] Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated
    Kennett, GA
    Trail, B
    Bright, F
    NEUROPHARMACOLOGY, 1998, 37 (12) : 1603 - 1610
  • [15] ARE MCPP-INDUCED BEHAVIORS 5-HT2C OR 5-HT2B RECEPTOR-MEDIATED
    TRAIL, B
    AINSWORTH, K
    BLACKBURN, TP
    BAXTER, GS
    KENNETT, GA
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 : P449 - P449
  • [16] Motoneuron Excitability and Muscle Spasms Are Regulated by 5-HT2B and 5-HT2C Receptor Activity
    Murray, Katherine C.
    Stephens, Marilee J.
    Ballou, Edmund W.
    Heckman, Charles J.
    Bennett, David J.
    JOURNAL OF NEUROPHYSIOLOGY, 2011, 105 (02) : 731 - 748
  • [17] Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy
    Schaerlinger, B
    Hickel, P
    Etienne, N
    Guesnier, L
    Maroteaux, L
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (02) : 277 - 284
  • [18] Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling
    Rashid, M
    Manivet, P
    Nishio, H
    Pratuangdejkul, J
    Rajab, M
    Ishiguro, M
    Launay, JM
    Nagatomo, T
    LIFE SCIENCES, 2003, 73 (02) : 193 - 207
  • [19] Effect of Combined Administration of Afobazole and 5-HT2b/2c Receptor Antagonist SB-200646A on Neurochemical Profile of Brain Structures in C57Bl/6 and BALB/c Mice
    K. S. Rayevsky
    V. B. Narkevich
    P. M. Klodt
    V. S. Kudrin
    Bulletin of Experimental Biology and Medicine, 2012, 153 : 689 - 693
  • [20] Effect of Combined Administration of Afobazole and 5-HT2b/2c Receptor Antagonist SB-200646A on Neurochemical Profile of Brain Structures in C57Bl/6 and BALB/c Mice
    Rayevsky, K. S.
    Narkevich, V. B.
    Klodt, P. M.
    Kudrin, V. S.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 153 (05) : 689 - 693